01 1Embio Limited
01 1PSEUDOEPHEDRINE SULFATE USP
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2022-10-06
Pay. Date : 2022-09-29
DMF Number : 35861
Submission : 2021-05-23
Status : Active
Type : II
20
Embio Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is PSEUDOEPHEDRINE SULFATE USP, with a corresponding US DMF Number 35861.
Remarkably, this DMF maintains an Active status since its submission on May 23, 2021, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 06, 2022, and payment made on September 29, 2022, indicating their dedication to facilitating drug approvals, Categorized as Type II
